| 1. | | No longer recruiting | Bryostatin 1 and Cisplatin in Treating Patients With Metastatic or Unresectable Stomach Cancer
Conditions: stage III gastric cancer; stage IV gastric cancer |
| 2. | | No longer recruiting | Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer
Conditions: recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ... |
| 3. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Advanced Cancer of the Pancreas
Conditions: stage IVA pancreatic cancer; stage IVB pancreatic cancer |
| 4. | | No longer recruiting | Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
Condition: recurrent ovarian epithelial cancer |
| 5. | | Completed | Cryosurgery in Treating Patients With Soft Tissue Sarcoma
Conditions: recurrent childhood rhabdomyosarcoma; recurrent childhood soft tissue sarcoma; previously untreated childhood rhabdomyosarcoma; ... |
| 6. | | Recruiting | Decitabine in Treating Patients With Advanced Solid Tumors
Conditions: adult solid tumor; Bladder Cancer; Breast Cancer; Male Breast Cancer; Melanoma |
| 7. | | Completed | Decitabine in Treating Patients With Melanoma or Other Advanced Cancer
Condition: Cancer |
| 8. | | No longer recruiting | IM-862 in Treating Patients With Recurrent Ovarian Cancer
Condition: recurrent ovarian epithelial cancer |
| 9. | | No longer recruiting | Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer
Condition: unspecified adult solid tumor, protocol specific |
| 10. | | No longer recruiting | Irinotecan in Treating Patients With Colorectal Cancer
Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer |
| 11. | | No longer recruiting | Laparoscopic Ultrasound in Diagnosing Patients With Pancreatic Cancer
Conditions: stage I pancreatic cancer; stage II pancreatic cancer |
| 12. | | Suspended | Monoclonal Antibody and Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma That Has Been Removed During Surgery
Conditions: iris melanoma; ciliary body and choroid melanoma, small size; ciliary body and choroid melanoma, medium/large size; extraocular extension melanoma; ... |
| 13. | | Recruiting | Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
Conditions: intraocular melanoma; Melanoma |
| 14. | | Recruiting | Peptide Vaccine, Montanide ISA 51, and CpG 7909 in Treating Patients With Resected Stage IIC, Stage III, or Stage IV Melanoma
Conditions: stage II melanoma; stage III melanoma; Stage IV Melanoma; iris melanoma; ciliary body and choroid melanoma, medium/large size; ... |
| 15. | | Completed | Prospective Comparison of Ampicillin / Amoxicillin Versus Ceftriaxone for the Treatment of Salmonella Infections in AIDS Patients
Conditions: HIV Infections; Salmonella Infections |
| 16. | | No longer recruiting | Radiation Therapy Plus Paclitaxel in Treating Patients With Stage IIB or Stage III Breast Cancer
Condition: Breast Cancer |
| 17. | | Recruiting | Safety and Efficacy of Targeted Gene Transfer in Colorectal Cancer Metastatic to Liver
Condition: Colorectal Neoplasms |
| 18. | | Recruiting | Vaccine Therapy and Interleukin-12 With Either Alum or Sargramostim After Surgery in Treating Patients With Melanoma
Conditions: intraocular melanoma; Melanoma |
| 19. | | No longer recruiting | Vaccine Therapy Followed by Biological Therapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma |
| 20. | | No longer recruiting | Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery
Condition: stage II melanoma |
| 21. | | No longer recruiting | Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: ciliary body and choroid melanoma, medium/large size; Stage IV Melanoma; extraocular extension melanoma; recurrent intraocular melanoma; ... |
| 22. | | No longer recruiting | Vaccine Therapy With or Without Interleukin-12 in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma; recurrent intraocular melanoma; stage III melanoma; Recurrent Melanoma |
| 23. | | Recruiting | Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma
Conditions: stage II melanoma; stage III melanoma; Stage IV Melanoma; iris melanoma; ciliary body and choroid melanoma, medium/large size; ... |
